Stocks News

LAST PRICE
109.8400
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
107.8000/ 1
Ask / Lots
113.0000/ 1
Open / Previous Close
0.0000 / 109.8400
Day Range
---
52 Week Range
Low 89.0000
High 201.1700
Volume
1,140
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jun 24, 2024
- Illumina Completes Grail Spin-Off Into Publicly Traded Entity, Holds Minority Stake, from 5:11PM ET on Monday Jun 24, 2024 by MT Newswires
  5:11PM ET on Monday Jun 24, 2024 by MT Newswires
  Companies Mentioned: ILMN
  05:11 PM EDT, 06/24/2024 (MT Newswires) -- Illumina (ILMN) late Monday said it has successfully spun off its former Grail cancer diagnostics unit into a stand-alone public company that will trade under the ticker GRAL starting Tuesday. As part of th...
- DJ Illumina Finishes Spinning Off Cancer-Test Maker Grail -- WSJ, from 5:05PM ET on Monday Jun 24, 2024 by Dow Jones
  5:05PM ET on Monday Jun 24, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  By Peter Loftus
  
  Grail is back to being an independent company after a tumultuous few years, and its CEO says its making progress toward broader use of its cancer-detection blood test.
- Illumina completes the divestiture of GRAIL, from 4:05PM ET on Monday Jun 24, 2024 by Dow Jones
  4:05PM ET on Monday Jun 24, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  Illumina completes the divestiture of GRAIL
  
  PR Newswire
  
  SAN DIEGO, June 24, 2024
  -- GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25 -- Illumina to issue second quarter 2024 results on August 6; leadership to present Strategy Update on August 13
Jun 20, 2024
- Every Role Makes a Difference: Four Illumina Employees Share Their Stories, from 9:47AM ET on Thursday Jun 20, 2024 by Dow Jones
  9:47AM ET on Thursday Jun 20, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  They come from diverse departments and backgrounds, but each is vital to making genomics useful and accessible to all
  
  NORTHAMPTON, MA / ACCESSWIRE / June 20, 2024 / Originally published on Illumina News Center
- Guggenheim Adjusts Price Target on Illumina to $138 From $159, Maintains Buy Rating, from 6:36AM ET on Thursday Jun 20, 2024 by MT Newswires
  6:36AM ET on Thursday Jun 20, 2024 by MT Newswires
  Companies Mentioned: ILMN
  06:36 AM EDT, 06/20/2024 (MT Newswires) -- Illumina (ILMN) has an average rating of outperform and price targets ranging from $100 to $249, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from...

Yesterday
- Oppenheimer Downgrades ResMed to Market Perform From Outperform, from 6:30AM ET on Tuesday Jun 25, 2024 by MT Newswires
  6:30AM ET on Tuesday Jun 25, 2024 by MT Newswires
  Companies Mentioned: RMD
Jun 24, 2024
- Top Premarket Decliners, from 7:56AM ET on Monday Jun 24, 2024 by MT Newswires
  7:56AM ET on Monday Jun 24, 2024 by MT Newswires
  Companies Mentioned: MSTR, RMD, GTHX, IREN, FUFU
Jun 20, 2024
- Bionano Genomics Says Revvity to Commercialize VIA Software, from 10:22AM ET on Thursday Jun 20, 2024 by MT Newswires
  10:22AM ET on Thursday Jun 20, 2024 by MT Newswires
  Companies Mentioned: RVTY, BNGO
Jun 11, 2024
- Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing, from 3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires
  3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires
  Companies Mentioned: RMD
Jun 10, 2024
- PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia, from 9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire
  9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire
  Companies Mentioned: RMD
May 29, 2024
- Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing, from 11:28AM ET on Wednesday May 29, 2024 by MT Newswires
  11:28AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: WAT
May 23, 2024
- ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea, from 10:37AM ET on Thursday May 23, 2024 by MT Newswires
  10:37AM ET on Thursday May 23, 2024 by MT Newswires
  Companies Mentioned: RMD
- Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy, from 9:05AM ET on Thursday May 23, 2024 by GlobeNewswire
  9:05AM ET on Thursday May 23, 2024 by GlobeNewswire
  Companies Mentioned: RMD
May 22, 2024
- Deutsche Bank Adjusts Waters Price Target to $330 From $304, from 8:53AM ET on Wednesday May 22, 2024 by MT Newswires
  8:53AM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: WAT
May 16, 2024
- ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy, from 4:35PM ET on Thursday May 16, 2024 by GlobeNewswire
  4:35PM ET on Thursday May 16, 2024 by GlobeNewswire
  Companies Mentioned: RMD

Illumina Inc
NASDAQ:ILMNUnited States

Search Criteria

Jun 24, 2024

Illumina Completes Grail Spin-Off Into Publicly Traded Entity, Holds Minority Stake, from 5:11PM ET on Monday Jun 24, 2024 by MT Newswires

DJ Illumina Finishes Spinning Off Cancer-Test Maker Grail -- WSJ, from 5:05PM ET on Monday Jun 24, 2024 by Dow Jones

Illumina completes the divestiture of GRAIL, from 4:05PM ET on Monday Jun 24, 2024 by Dow Jones

Jun 20, 2024

Every Role Makes a Difference: Four Illumina Employees Share Their Stories, from 9:47AM ET on Thursday Jun 20, 2024 by Dow Jones

Guggenheim Adjusts Price Target on Illumina to $138 From $159, Maintains Buy Rating, from 6:36AM ET on Thursday Jun 20, 2024 by MT Newswires

Peers Headlines

Yesterday

Oppenheimer Downgrades ResMed to Market Perform From Outperform, from 6:30AM ET on Tuesday Jun 25, 2024 by MT Newswires

Jun 24, 2024

Top Premarket Decliners, from 7:56AM ET on Monday Jun 24, 2024 by MT Newswires

Jun 20, 2024

Bionano Genomics Says Revvity to Commercialize VIA Software, from 10:22AM ET on Thursday Jun 20, 2024 by MT Newswires

Jun 11, 2024

Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing, from 3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires

Jun 10, 2024

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia, from 9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire

May 29, 2024

Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing, from 11:28AM ET on Wednesday May 29, 2024 by MT Newswires

May 23, 2024

ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea, from 10:37AM ET on Thursday May 23, 2024 by MT Newswires

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy, from 9:05AM ET on Thursday May 23, 2024 by GlobeNewswire

May 22, 2024

Deutsche Bank Adjusts Waters Price Target to $330 From $304, from 8:53AM ET on Wednesday May 22, 2024 by MT Newswires

May 16, 2024

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy, from 4:35PM ET on Thursday May 16, 2024 by GlobeNewswire